Want to join the conversation?
$OREX 2Q15 PR: OREX & Takeda Pharmaceutical Co. Limited executed an amended & restated collaboration agreement realigning partnership for Contrave’s success in US & resolving all disputes between parties. Contrave became leading branded weight loss medicine. IMS Health said, 172,050 prescriptions were filled in 2Q15, 47% increase over 1Q15.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!